BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9375749)

  • 1. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines.
    Komada Y; Inaba H; Zhou YW; Zhang XL; Tanaka S; Azuma E; Sakurai M
    Br J Haematol; 1997 Nov; 99(2):325-30. PubMed ID: 9375749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells.
    Zhou YW; Komada Y; Inaba H; Azuma E; Sakurai M
    Cell Immunol; 1998 Jun; 186(2):103-10. PubMed ID: 9665752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells.
    Jo SK; Cha DR; Cho WY; Kim HK; Chang KH; Yun SY; Won NH
    Nephron; 2002 Jul; 91(3):406-15. PubMed ID: 12119470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
    Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
    Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines.
    Dirks W; Schöne S; Uphoff C; Quentmeier H; Pradella S; Drexler HG
    Br J Haematol; 1997 Mar; 96(3):584-93. PubMed ID: 9054667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of tumor necrosis factor-alpha signaling adapter proteins in peripheral blood mononuclear cells from patients with systemic lupus erythematosus].
    Zhu LJ; Yang X; Chen WY; Li XY; Ji YL; Mao HP; Nie J; Yu XQ
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3102-6. PubMed ID: 18269865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential signaling to apoptotic and necrotic cell death by Fas-associated death domain protein FADD.
    Vanden Berghe T; van Loo G; Saelens X; Van Gurp M; Brouckaert G; Kalai M; Declercq W; Vandenabeele P
    J Biol Chem; 2004 Feb; 279(9):7925-33. PubMed ID: 14668343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation.
    Rochat-Steiner V; Becker K; Micheau O; Schneider P; Burns K; Tschopp J
    J Exp Med; 2000 Oct; 192(8):1165-74. PubMed ID: 11034606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
    Yao H; Song E; Chen J; Hamar P
    Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other.
    Varfolomeev EE; Boldin MP; Goncharov TM; Wallach D
    J Exp Med; 1996 Mar; 183(3):1271-5. PubMed ID: 8642271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.
    Holler N; Zaru R; Micheau O; Thome M; Attinger A; Valitutti S; Bodmer JL; Schneider P; Seed B; Tschopp J
    Nat Immunol; 2000 Dec; 1(6):489-95. PubMed ID: 11101870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells.
    Lajmanovich A; Irisarri M; Molens JP; Pasquier MA; Sotto JJ; Bensa JC; Leroux D; Plumas J
    Br J Haematol; 2004 Mar; 124(6):746-53. PubMed ID: 15009062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer.
    Meinhold-Heerlein I; Stenner-Liewen F; Liewen H; Kitada S; Krajewska M; Krajewski S; Zapata JM; Monks A; Scudiero DA; Bauknecht T; Reed JC
    Am J Pathol; 2001 Apr; 158(4):1335-44. PubMed ID: 11290551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression.
    Yeh JH; Hsu SC; Han SH; Lai MZ
    J Exp Med; 1998 Nov; 188(10):1795-802. PubMed ID: 9815257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of FADD/ MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase.
    Scaffidi C; Volkland J; Blomberg I; Hoffmann I; Krammer PH; Peter ME
    J Immunol; 2000 Feb; 164(3):1236-42. PubMed ID: 10640736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells.
    Morgan MJ; Thorburn J; Thomas L; Maxwell T; Brothman AR; Thorburn A
    Cell Death Differ; 2001 Jul; 8(7):696-705. PubMed ID: 11464214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells.
    Mueller CM; Scott DW
    J Immunol; 2000 Aug; 165(4):1854-62. PubMed ID: 10925264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis.
    Lin Y; Devin A; Rodriguez Y; Liu ZG
    Genes Dev; 1999 Oct; 13(19):2514-26. PubMed ID: 10521396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFkappaB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP.
    Kreuz S; Siegmund D; Rumpf JJ; Samel D; Leverkus M; Janssen O; Häcker G; Dittrich-Breiholz O; Kracht M; Scheurich P; Wajant H
    J Cell Biol; 2004 Aug; 166(3):369-80. PubMed ID: 15289496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Support for an infection-induced apoptotic pathway in human fetal membranes.
    Fortunato SJ; Menon R; Lombardi SJ
    Am J Obstet Gynecol; 2001 Jun; 184(7):1392-7; discussion 1397-8. PubMed ID: 11408858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.